If you take blood thinners, antiplatelet medicines or medicines for a heart condition, tell the medical cannabis clinic before any prescribing decision. This is a high-risk medicines topic because small changes in bleeding, heart rhythm, blood pressure, fainting or chest symptoms can matter.
The article cannot tell you whether medical cannabis is suitable with your medicines. It cannot manage an interaction, interpret blood tests, or say cannabis is safe for heart disease. The useful patient action is to give the prescriber and pharmacist a complete medicine list and a clear account of heart symptoms.
This is general UK patient information, not medical advice. For the wider route, start with the MCPH patient guide and the broader guide to medical cannabis and medication interactions.
The short answer
NHS medical cannabis guidance says CBD and THC can affect how other medicines work. That is enough reason to disclose blood thinners and cardiovascular medicines before medical cannabis is considered.
Tell the clinic if you take:
- anticoagulants such as warfarin, apixaban, rivaroxaban, dabigatran or edoxaban
- antiplatelet medicines such as aspirin, clopidogrel, prasugrel or ticagrelor
- medicines for heart rhythm, angina, heart failure, blood pressure or cholesterol
- beta blockers, calcium channel blockers, ACE inhibitors, ARBs, diuretics, nitrates, antiarrhythmics or statins
- over-the-counter medicines, supplements, CBD products or non-prescribed cannabis
Also disclose chest pain, fainting, palpitations, breathlessness, falls, unusual bruising, bleeding, very high or low blood pressure episodes, recent hospital care, stroke/TIA history, heart rhythm problems and any recent medicine changes.
Do not stop, reduce, add, swap or alter heart medicines or blood thinners because of an article. These medicines can be prescribed to reduce serious risks, and changes need the responsible clinician.
Why blood thinners need careful review
Anticoagulants and antiplatelets are used to reduce clotting risk in conditions such as atrial fibrillation, previous clots, stroke prevention, heart valve problems, heart attacks or stents. They can also increase bleeding risk. That makes interaction questions important.
The prescriber needs to know which blood thinner you take, why you take it, whether the dose is stable, whether you have had bleeding or clotting problems, and whether monitoring is involved. Warfarin, for example, is monitored differently from direct oral anticoagulants such as apixaban or rivaroxaban. This article cannot interpret any of that for you.
Signs such as unexplained bruising, nosebleeds, blood in urine or stool, prolonged bleeding, severe headache after a fall, black stools or coughing/vomiting blood need appropriate medical advice. If symptoms are severe or feel urgent, use urgent medical help rather than waiting for a cannabis-clinic reply.
Heart medicines and symptoms to disclose
Heart medicines are not all the same. Some affect heart rate, rhythm, blood pressure, fluid balance, chest pain, cholesterol or clot risk. A medical cannabis prescriber needs to know the actual medicine names and the reason they were prescribed.
Be clear about:
- atrial fibrillation, other rhythm problems or palpitations
- high blood pressure, low blood pressure or fainting
- angina, chest pain, heart attack history or stents
- heart failure, valve disease, cardiomyopathy or congenital heart disease
- stroke or TIA history
- dizziness, falls, blackouts or near-fainting episodes
- breathlessness, ankle swelling or sudden changes in exercise tolerance
Medical cannabis can cause side effects such as dizziness, tiredness, feeling high, mood changes and impairment. If a patient already has fainting, falls, blood pressure problems or rhythm symptoms, those details need clinical review. This is not proof that cannabis is unsafe for every heart patient, and it is not proof that it is safe. It means the assessment must be careful.
For related background, read MCPH’s guides to medical cannabis side effects and THC side effects and impairment.
What the clinic and pharmacist need
Bring the most complete medicine list you can. Include:
- medicine name, strength and how often you take it, as prescribed
- the reason for each medicine if you know it
- the clinician or service that manages it
- recent changes, missed medicines or side effects
- over-the-counter painkillers, stomach medicines, supplements and CBD products
- alcohol and non-prescribed cannabis use
- recent blood tests, INR results or clinic letters if the clinic asks for them
The Summary Care Record from the GP surgery may show current and recent medicines, allergies and coded conditions. For heart disease or anticoagulation, a clinic may also ask for cardiology letters, anticoagulation clinic notes, hospital discharge letters or recent results if the SCR does not show enough detail.
That is a records step. It is not asking the GP to approve medical cannabis.
Driving, work and falls risk
Heart medicines, blood pressure changes, dizziness, fainting and impairment can affect daily safety. So can medical cannabis. Alcohol, sedatives, pain medicines and other drugs can add to that risk.
If driving or safety-sensitive work is part of your life, raise it directly. A prescription is not blanket driving clearance. If you feel impaired, dizzy, faint, unusually tired, high or confused, do not drive. Read MCPH’s guide to medical cannabis and driving in the UK for the wider boundary.
Falls matter too. A fall can be more serious for someone taking a blood thinner. If you have had recent falls, blackouts, near-faints or balance problems, tell the prescriber.
Questions to ask the clinic
Useful questions include:
- Which of my blood thinners, antiplatelets or heart medicines need pharmacist review?
- What heart symptoms would make you pause assessment or ask for cardiology input?
- Do my fainting, blood pressure, rhythm or chest-pain history change the risk discussion?
- What bleeding symptoms should be treated as urgent?
- Who should I contact if another clinician changes my heart medicine or blood thinner?
- How do alcohol, sedatives, pain medicines or CBD products affect the review?
- How do you handle driving, falls and safety-sensitive work in this assessment?
These questions do not ask the article to manage the interaction. They help the clinical team explain the review.
What this article is not saying
This article is not saying medical cannabis is safe for heart disease. It is not saying heart disease or blood thinners automatically rule out medical cannabis. It is not recommending CBD, THC, flower, oil, extracts, a clinic, a pharmacy, a dose, a route, a monitoring plan or a medicine change.
It is saying that anticoagulants, antiplatelets, heart rhythm medicines, blood pressure medicines, chest pain, fainting, palpitations, bleeding symptoms and cardiovascular history must be disclosed. The decision belongs with the prescriber and pharmacist, with input from the patient’s usual heart or anticoagulation team where needed.
Sources
- NHS: Medical cannabis
- NHS: Anticoagulant medicines
- NHS: Anticoagulant medicines – considerations
- NHS: Apixaban
- NHS: Atrial fibrillation
- NICE: Cannabis-based medicinal products, NG144
- NHS England: Cannabis-based products for medicinal use
- GMC: Information for doctors on cannabis-based products for medicinal use
- CQC: Cannabis-based medicinal products: what CQC looks for when providers register
- GOV.UK: Drug driving law
